Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,636 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nuclear medicine practice in Japan: a report of the ninth nationwide survey in 2022.
Okizaki A, Nishiyama Y, Inui Y, Otsuka H, Takanami K, Nakajo M, Nakatani K, Nogami M, Hirata K, Maeda Y, Yoshimura M, Wakabayashi H. Okizaki A, et al. Among authors: yoshimura m. Ann Nucl Med. 2024 Apr;38(4):315-327. doi: 10.1007/s12149-024-01905-9. Epub 2024 Feb 29. Ann Nucl Med. 2024. PMID: 38421515
Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy.
Kusakabe K, Yokoyama K, Ito K, Shibuya H, Kinuya S, Ito M, Higashi T, Togawa T, Koizumi K, Yoshimura M, Uchiyama M, Okamoto T, Kanaya S, Kanaya K, Yoneyama T, Ikebuchi H, Yanagida S, Shibata K, Segawa K, Yamamoto A. Kusakabe K, et al. Among authors: yoshimura m. Ann Nucl Med. 2012 May;26(4):370-8. doi: 10.1007/s12149-012-0590-7. Epub 2012 Mar 27. Ann Nucl Med. 2012. PMID: 22450825
Full report on a survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan.
Matsuda H, Uehara T, Okazawa H, Mizumura S, Yokoyama K, Yoshimura M; Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association. Matsuda H, et al. Among authors: yoshimura m. Ann Nucl Med. 2020 Apr;34(4):299-304. doi: 10.1007/s12149-020-01439-w. Epub 2020 Jan 27. Ann Nucl Med. 2020. PMID: 31989466
[The 42nd Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 45th Survey in 2019)].
Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association; Okazawa H, Uehara T, Kuji I, Higashi T, Yoshimura M. Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association, et al. Among authors: yoshimura m. Kaku Igaku. 2021;58(1):1-11. doi: 10.18893/kakuigaku.rp.2131. Kaku Igaku. 2021. PMID: 33612568 Free article. Japanese.
[The 43rd Report on the Survey of Adverse Reactions to Radiopharmaceuticals (46th Survey in 2020)].
Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association; Okazawa H, Uehara T, Kuji I, Higashi T, Yoshimura M. Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association, et al. Among authors: yoshimura m. Kaku Igaku. 2022;59(1):1-12. doi: 10.18893/kakuigaku.rp.2231. Kaku Igaku. 2022. PMID: 35321966 Free article. Japanese.
2,636 results